カテゴリー： 世界, 医療/バイオ, LP Information

世界のプロカルバジン市場予測 2023年-2029年

【英語タイトル】Global Procarbazine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07808）・商品コード：LP23DC07808
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のプロカルバジン市場」は、過去の販売実績から2022年の世界のプロカルバジンの総販売量を検討し、2023年から2029年の予測されるプロカルバジンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のプロカルバジンの市場規模を掲載し、XXX百万米ドル規模の世界のプロカルバジン市場の詳細な分析を提供します。本インサイトレポートは、世界のプロカルバジン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のプロカルバジン市場における各社の独自のポジションをより深く理解するために、プロカルバジン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のプロカルバジン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。プロカルバジンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。プロカルバジンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。プロカルバジンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

プロカルバジンの世界主要メーカーとしては、F. Hoffmann-La Roche Ltd.、 Pfizer Inc.、 Novartis AG、 Leadiant Biosciences、 Chemspec-API、 ChemPacific、 Macklin Inc.、 ChemPacific、 Alliance Pharmaceuticals、 Matulane、 Fagronなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のプロカルバジン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではプロカルバジン市場をセグメンテーションし、種類別 (50mg、25mg、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：50mg、25mg、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のプロカルバジン市場の10年間の市場状況・展望は？
・世界および地域別に見たプロカルバジン市場成長の要因は何か？
・プロカルバジンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・プロカルバジンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：プロカルバジンの年間販売量2018-2029、地域別現状・将来分析
・プロカルバジンの種類別セグメント：50mg、25mg、その他
・プロカルバジンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・プロカルバジンの用途別セグメント：病院、診療所、その他
・プロカルバジンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のプロカルバジン市場
・企業別のグローバルプロカルバジン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のプロカルバジンの年間売上：2018-2023年の売上、市場シェア
・企業別のプロカルバジン販売価格
・主要企業のプロカルバジン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

プロカルバジンの地域別レビュー
・地域別のプロカルバジン市場規模2018-2023：年間販売量、売上
・主要国別のプロカルバジン市場規模2018-2023：年間販売量、売上
・南北アメリカのプロカルバジン販売の成長
・アジア太平洋のプロカルバジン販売の成長
・ヨーロッパのプロカルバジン販売の成長
・中東・アフリカのプロカルバジン販売の成長

南北アメリカ市場
・南北アメリカの国別のプロカルバジン販売量、売上（2018-2023）
・南北アメリカのプロカルバジンの種類別販売量
・南北アメリカのプロカルバジンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のプロカルバジン販売量、売上（2018-2023）
・アジア太平洋のプロカルバジンの種類別販売量
・アジア太平洋のプロカルバジンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のプロカルバジン販売量、売上（2018-2023）
・ヨーロッパのプロカルバジンの種類別販売量
・ヨーロッパのプロカルバジンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のプロカルバジン販売量、売上（2018-2023）
・中東・アフリカのプロカルバジンの種類別販売量
・中東・アフリカのプロカルバジンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・プロカルバジンの製造コスト構造分析
・プロカルバジンの製造プロセス分析
・プロカルバジンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・プロカルバジンの主要なグローバル販売業者
・プロカルバジンの主要なグローバル顧客

地域別のプロカルバジン市場予測レビュー
・地域別のプロカルバジン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・プロカルバジンの種類別市場規模予測
・プロカルバジンの用途別市場規模予測

主要企業分析
F. Hoffmann-La Roche Ltd.、 Pfizer Inc.、 Novartis AG、 Leadiant Biosciences、 Chemspec-API、 ChemPacific、 Macklin Inc.、 ChemPacific、 Alliance Pharmaceuticals、 Matulane、 Fagron
・企業情報
・プロカルバジン製品
・プロカルバジン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Procarbazine market size is projected to grow from US$ 2142.4 million in 2022 to US$ 2788.7 million in 2029; it is expected to grow at a CAGR of 3.8% from 2023 to 2029.
United States market for Procarbazine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Procarbazine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Procarbazine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Procarbazine players cover F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Leadiant Biosciences, Chemspec-API, ChemPacific, Macklin Inc., ChemPacific and Alliance Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Procarbazine is a chemotherapy medication used for the treatment of Hodgkin’s lymphoma and brain cancers. For Hodgkin’s it is often used together with chlormethine, vincristine, and prednisone while for brain cancers such as glioblastoma multiforme it is used with lomustine and vincristine. It is typically taken by mouth.
LPI (LP Information)’ newest research report, the “Procarbazine Industry Forecast” looks at past sales and reviews total world Procarbazine sales in 2022, providing a comprehensive analysis by region and market sector of projected Procarbazine sales for 2023 through 2029. With Procarbazine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Procarbazine industry.
This Insight Report provides a comprehensive analysis of the global Procarbazine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Procarbazine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Procarbazine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Procarbazine and breaks down the forecast by tablets, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Procarbazine.
This report presents a comprehensive overview, market shares, and growth opportunities of Procarbazine market by product tablets, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by tablets
50 mg
25 mg
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche Ltd.
Pfizer Inc.
Novartis AG
Leadiant Biosciences
Chemspec-API
ChemPacific
Macklin Inc.
ChemPacific
Alliance Pharmaceuticals
Matulane
Fagron
Key Questions Addressed in this Report
What is the 10-year outlook for the global Procarbazine market?
What factors are driving Procarbazine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Procarbazine market opportunities vary by end market size?
How does Procarbazine break out tablets, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Procarbazine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Procarbazine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Procarbazine by Country/Region, 2018, 2022 & 2029
2.2 Procarbazine Segment by Tablets
2.2.1 50 mg
2.2.2 25 mg
2.2.3 Others
2.3 Procarbazine Sales by Tablets
2.3.1 Global Procarbazine Sales Market Share by Tablets (2018-2023)
2.3.2 Global Procarbazine Revenue and Market Share by Tablets (2018-2023)
2.3.3 Global Procarbazine Sale Price by Tablets (2018-2023)
2.4 Procarbazine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Procarbazine Sales by Application
2.5.1 Global Procarbazine Sale Market Share by Application (2018-2023)
2.5.2 Global Procarbazine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Procarbazine Sale Price by Application (2018-2023)
3 Global Procarbazine by Company
3.1 Global Procarbazine Breakdown Data by Company
3.1.1 Global Procarbazine Annual Sales by Company (2018-2023)
3.1.2 Global Procarbazine Sales Market Share by Company (2018-2023)
3.2 Global Procarbazine Annual Revenue by Company (2018-2023)
3.2.1 Global Procarbazine Revenue by Company (2018-2023)
3.2.2 Global Procarbazine Revenue Market Share by Company (2018-2023)
3.3 Global Procarbazine Sale Price by Company
3.4 Key Manufacturers Procarbazine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Procarbazine Product Location Distribution
3.4.2 Players Procarbazine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Procarbazine by Geographic Region
4.1 World Historic Procarbazine Market Size by Geographic Region (2018-2023)
4.1.1 Global Procarbazine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Procarbazine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Procarbazine Market Size by Country/Region (2018-2023)
4.2.1 Global Procarbazine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Procarbazine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Procarbazine Sales Growth
4.4 APAC Procarbazine Sales Growth
4.5 Europe Procarbazine Sales Growth
4.6 Middle East & Africa Procarbazine Sales Growth
5 Americas
5.1 Americas Procarbazine Sales by Country
5.1.1 Americas Procarbazine Sales by Country (2018-2023)
5.1.2 Americas Procarbazine Revenue by Country (2018-2023)
5.2 Americas Procarbazine Sales by Tablets
5.3 Americas Procarbazine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Procarbazine Sales by Region
6.1.1 APAC Procarbazine Sales by Region (2018-2023)
6.1.2 APAC Procarbazine Revenue by Region (2018-2023)
6.2 APAC Procarbazine Sales by Tablets
6.3 APAC Procarbazine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Procarbazine by Country
7.1.1 Europe Procarbazine Sales by Country (2018-2023)
7.1.2 Europe Procarbazine Revenue by Country (2018-2023)
7.2 Europe Procarbazine Sales by Tablets
7.3 Europe Procarbazine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Procarbazine by Country
8.1.1 Middle East & Africa Procarbazine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Procarbazine Revenue by Country (2018-2023)
8.2 Middle East & Africa Procarbazine Sales by Tablets
8.3 Middle East & Africa Procarbazine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Procarbazine
10.3 Manufacturing Process Analysis of Procarbazine
10.4 Industry Chain Structure of Procarbazine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Procarbazine Distributors
11.3 Procarbazine Customer
12 World Forecast Review for Procarbazine by Geographic Region
12.1 Global Procarbazine Market Size Forecast by Region
12.1.1 Global Procarbazine Forecast by Region (2024-2029)
12.1.2 Global Procarbazine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Procarbazine Forecast by Tablets
12.7 Global Procarbazine Forecast by Application
13 Key Players Analysis
13.1 F. Hoffmann-La Roche Ltd.
13.1.1 F. Hoffmann-La Roche Ltd. Company Information
13.1.2 F. Hoffmann-La Roche Ltd. Procarbazine Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Ltd. Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.1.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Procarbazine Product Portfolios and Specifications
13.2.3 Pfizer Inc. Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Procarbazine Product Portfolios and Specifications
13.3.3 Novartis AG Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Leadiant Biosciences
13.4.1 Leadiant Biosciences Company Information
13.4.2 Leadiant Biosciences Procarbazine Product Portfolios and Specifications
13.4.3 Leadiant Biosciences Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Leadiant Biosciences Main Business Overview
13.4.5 Leadiant Biosciences Latest Developments
13.5 Chemspec-API
13.5.1 Chemspec-API Company Information
13.5.2 Chemspec-API Procarbazine Product Portfolios and Specifications
13.5.3 Chemspec-API Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chemspec-API Main Business Overview
13.5.5 Chemspec-API Latest Developments
13.6 ChemPacific
13.6.1 ChemPacific Company Information
13.6.2 ChemPacific Procarbazine Product Portfolios and Specifications
13.6.3 ChemPacific Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ChemPacific Main Business Overview
13.6.5 ChemPacific Latest Developments
13.7 Macklin Inc.
13.7.1 Macklin Inc. Company Information
13.7.2 Macklin Inc. Procarbazine Product Portfolios and Specifications
13.7.3 Macklin Inc. Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Macklin Inc. Main Business Overview
13.7.5 Macklin Inc. Latest Developments
13.8 ChemPacific
13.8.1 ChemPacific Company Information
13.8.2 ChemPacific Procarbazine Product Portfolios and Specifications
13.8.3 ChemPacific Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ChemPacific Main Business Overview
13.8.5 ChemPacific Latest Developments
13.9 Alliance Pharmaceuticals
13.9.1 Alliance Pharmaceuticals Company Information
13.9.2 Alliance Pharmaceuticals Procarbazine Product Portfolios and Specifications
13.9.3 Alliance Pharmaceuticals Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Alliance Pharmaceuticals Main Business Overview
13.9.5 Alliance Pharmaceuticals Latest Developments
13.10 Matulane
13.10.1 Matulane Company Information
13.10.2 Matulane Procarbazine Product Portfolios and Specifications
13.10.3 Matulane Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Matulane Main Business Overview
13.10.5 Matulane Latest Developments
13.11 Fagron
13.11.1 Fagron Company Information
13.11.2 Fagron Procarbazine Product Portfolios and Specifications
13.11.3 Fagron Procarbazine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Fagron Main Business Overview
13.11.5 Fagron Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Procarbazine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Procarbazine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 50 mg
Table 4. Major Players of 25 mg
Table 5. Major Players of Others
Table 6. Global Procarbazine Sales by Tablets (2018-2023) & (K Units)
Table 7. Global Procarbazine Sales Market Share by Tablets (2018-2023)
Table 8. Global Procarbazine Revenue by Tablets (2018-2023) & ($ million)
Table 9. Global Procarbazine Revenue Market Share by Tablets (2018-2023)
Table 10. Global Procarbazine Sale Price by Tablets (2018-2023) & (US$/Unit)
Table 11. Global Procarbazine Sales by Application (2018-2023) & (K Units)
Table 12. Global Procarbazine Sales Market Share by Application (2018-2023)
Table 13. Global Procarbazine Revenue by Application (2018-2023)
Table 14. Global Procarbazine Revenue Market Share by Application (2018-2023)
Table 15. Global Procarbazine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Procarbazine Sales by Company (2018-2023) & (K Units)
Table 17. Global Procarbazine Sales Market Share by Company (2018-2023)
Table 18. Global Procarbazine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Procarbazine Revenue Market Share by Company (2018-2023)
Table 20. Global Procarbazine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Procarbazine Producing Area Distribution and Sales Area
Table 22. Players Procarbazine Products Offered
Table 23. Procarbazine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Procarbazine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Procarbazine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Procarbazine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Procarbazine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Procarbazine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Procarbazine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Procarbazine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Procarbazine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Procarbazine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Procarbazine Sales Market Share by Country (2018-2023)
Table 36. Americas Procarbazine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Procarbazine Revenue Market Share by Country (2018-2023)
Table 38. Americas Procarbazine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Procarbazine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Procarbazine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Procarbazine Sales Market Share by Region (2018-2023)
Table 42. APAC Procarbazine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Procarbazine Revenue Market Share by Region (2018-2023)
Table 44. APAC Procarbazine Sales by Tablets (2018-2023) & (K Units)
Table 45. APAC Procarbazine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Procarbazine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Procarbazine Sales Market Share by Country (2018-2023)
Table 48. Europe Procarbazine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Procarbazine Revenue Market Share by Country (2018-2023)
Table 50. Europe Procarbazine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Procarbazine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Procarbazine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Procarbazine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Procarbazine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Procarbazine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Procarbazine Sales by Tablets (2018-2023) & (K Units)
Table 57. Middle East & Africa Procarbazine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Procarbazine
Table 59. Key Market Challenges & Risks of Procarbazine
Table 60. Key Industry Trends of Procarbazine
Table 61. Procarbazine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Procarbazine Distributors List
Table 64. Procarbazine Customer List
Table 65. Global Procarbazine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Procarbazine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Procarbazine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Procarbazine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Procarbazine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Procarbazine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Procarbazine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Procarbazine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Procarbazine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Procarbazine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Procarbazine Sales Forecast by Tablets (2024-2029) & (K Units)
Table 76. Global Procarbazine Revenue Forecast by Tablets (2024-2029) & ($ Millions)
Table 77. Global Procarbazine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Procarbazine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. F. Hoffmann-La Roche Ltd. Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 80. F. Hoffmann-La Roche Ltd. Procarbazine Product Portfolios and Specifications
Table 81. F. Hoffmann-La Roche Ltd. Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. F. Hoffmann-La Roche Ltd. Main Business
Table 83. F. Hoffmann-La Roche Ltd. Latest Developments
Table 84. Pfizer Inc. Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Inc. Procarbazine Product Portfolios and Specifications
Table 86. Pfizer Inc. Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Pfizer Inc. Main Business
Table 88. Pfizer Inc. Latest Developments
Table 89. Novartis AG Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis AG Procarbazine Product Portfolios and Specifications
Table 91. Novartis AG Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Novartis AG Main Business
Table 93. Novartis AG Latest Developments
Table 94. Leadiant Biosciences Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 95. Leadiant Biosciences Procarbazine Product Portfolios and Specifications
Table 96. Leadiant Biosciences Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Leadiant Biosciences Main Business
Table 98. Leadiant Biosciences Latest Developments
Table 99. Chemspec-API Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 100. Chemspec-API Procarbazine Product Portfolios and Specifications
Table 101. Chemspec-API Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Chemspec-API Main Business
Table 103. Chemspec-API Latest Developments
Table 104. ChemPacific Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 105. ChemPacific Procarbazine Product Portfolios and Specifications
Table 106. ChemPacific Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. ChemPacific Main Business
Table 108. ChemPacific Latest Developments
Table 109. Macklin Inc. Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 110. Macklin Inc. Procarbazine Product Portfolios and Specifications
Table 111. Macklin Inc. Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Macklin Inc. Main Business
Table 113. Macklin Inc. Latest Developments
Table 114. ChemPacific Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 115. ChemPacific Procarbazine Product Portfolios and Specifications
Table 116. ChemPacific Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. ChemPacific Main Business
Table 118. ChemPacific Latest Developments
Table 119. Alliance Pharmaceuticals Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 120. Alliance Pharmaceuticals Procarbazine Product Portfolios and Specifications
Table 121. Alliance Pharmaceuticals Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Alliance Pharmaceuticals Main Business
Table 123. Alliance Pharmaceuticals Latest Developments
Table 124. Matulane Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 125. Matulane Procarbazine Product Portfolios and Specifications
Table 126. Matulane Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Matulane Main Business
Table 128. Matulane Latest Developments
Table 129. Fagron Basic Information, Procarbazine Manufacturing Base, Sales Area and Its Competitors
Table 130. Fagron Procarbazine Product Portfolios and Specifications
Table 131. Fagron Procarbazine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Fagron Main Business
Table 133. Fagron Latest Developments
List of Figures
Figure 1. Picture of Procarbazine
Figure 2. Procarbazine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Procarbazine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Procarbazine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Procarbazine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 50 mg
Figure 10. Product Picture of 25 mg
Figure 11. Product Picture of Others
Figure 12. Global Procarbazine Sales Market Share by Tablets in 2022
Figure 13. Global Procarbazine Revenue Market Share by Tablets (2018-2023)
Figure 14. Procarbazine Consumed in Hospital
Figure 15. Global Procarbazine Market: Hospital (2018-2023) & (K Units)
Figure 16. Procarbazine Consumed in Clinic
Figure 17. Global Procarbazine Market: Clinic (2018-2023) & (K Units)
Figure 18. Procarbazine Consumed in Others
Figure 19. Global Procarbazine Market: Others (2018-2023) & (K Units)
Figure 20. Global Procarbazine Sales Market Share by Application (2022)
Figure 21. Global Procarbazine Revenue Market Share by Application in 2022
Figure 22. Procarbazine Sales Market by Company in 2022 (K Units)
Figure 23. Global Procarbazine Sales Market Share by Company in 2022
Figure 24. Procarbazine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Procarbazine Revenue Market Share by Company in 2022
Figure 26. Global Procarbazine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Procarbazine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Procarbazine Sales 2018-2023 (K Units)
Figure 29. Americas Procarbazine Revenue 2018-2023 ($ Millions)
Figure 30. APAC Procarbazine Sales 2018-2023 (K Units)
Figure 31. APAC Procarbazine Revenue 2018-2023 ($ Millions)
Figure 32. Europe Procarbazine Sales 2018-2023 (K Units)
Figure 33. Europe Procarbazine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Procarbazine Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Procarbazine Revenue 2018-2023 ($ Millions)
Figure 36. Americas Procarbazine Sales Market Share by Country in 2022
Figure 37. Americas Procarbazine Revenue Market Share by Country in 2022
Figure 38. Americas Procarbazine Sales Market Share by Tablets (2018-2023)
Figure 39. Americas Procarbazine Sales Market Share by Application (2018-2023)
Figure 40. United States Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Procarbazine Sales Market Share by Region in 2022
Figure 45. APAC Procarbazine Revenue Market Share by Regions in 2022
Figure 46. APAC Procarbazine Sales Market Share by Tablets (2018-2023)
Figure 47. APAC Procarbazine Sales Market Share by Application (2018-2023)
Figure 48. China Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Procarbazine Sales Market Share by Country in 2022
Figure 56. Europe Procarbazine Revenue Market Share by Country in 2022
Figure 57. Europe Procarbazine Sales Market Share by Tablets (2018-2023)
Figure 58. Europe Procarbazine Sales Market Share by Application (2018-2023)
Figure 59. Germany Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Procarbazine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Procarbazine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Procarbazine Sales Market Share by Tablets (2018-2023)
Figure 67. Middle East & Africa Procarbazine Sales Market Share by Application (2018-2023)
Figure 68. Egypt Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Procarbazine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Procarbazine in 2022
Figure 74. Manufacturing Process Analysis of Procarbazine
Figure 75. Industry Chain Structure of Procarbazine
Figure 76. Channels of Distribution
Figure 77. Global Procarbazine Sales Market Forecast by Region (2024-2029)
Figure 78. Global Procarbazine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Procarbazine Sales Market Share Forecast by Tablets (2024-2029)
Figure 80. Global Procarbazine Revenue Market Share Forecast by Tablets (2024-2029)
Figure 81. Global Procarbazine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Procarbazine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のプロカルバジン市場予測 2023年-2029年] (コード：LP23DC07808)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロカルバジン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のPVC手動蘇生器市場予測 2023年-2029年
  • 世界のマルチビタミンミネラル市場予測 2023年-2029年
  • 世界の義肢装具市場予測 2023年-2029年
  • 世界のワイヤレス外科用ヘッドライト市場予測 2023年-2029年
  • 世界の非ベンゾジアゼピン系薬剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆